Русский / English
Enter the query
06.09.2018
PETROVAX PHARM CELEBRATED AN ANNIVERSATY WITH THE LAUNCH OF THE FIRST RUSSIAN 4-VALENT ANTIFLU VACCINE PRODUCTION LINE

In 2018, Petrovax Pharm’s pharmaceutical complex in Moscow Region marked its 10th anniversary. The company has commemorated the event by manufacturing the first batches of Grippol®Quadrivalent and making a presentation of the third production line for API as well as suppository and tablet dosage forms.


Grippol® Quadrivalent, a 4-valent inactivated subunit adjuvanted vaccine, is manufactured in Russia full-cycle; it is preservative-free and is supplied in single-shot syringes to protect against four influenza virus strains, i.e. two flu type A viruses (H1N1 and H3N2) and two type B viral cell lines (B/Yamagata + B/Victoria).

«Petrovax Pharm has been an Interros company since 2014. For us, it is an important investment and a significant socially beneficial asset. We have come a long way over these years and may maintain that our cooperation is an effective business partnership model that has contributed to the implementation of large-scale international projects, geographic footprint extension, and market launch of new products», says Alexey Bashkirov, CEO of the Interros Holding Company.